Results 1 to 10 of about 7,455,591 (355)
Remdesivir for the Treatment of Covid-19 — Final Report
Background Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.
J. Beigel+39 more
semanticscholar +1 more source
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
BACKGROUND Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of the disease, relatively little is known about the associated morphologic ...
M. Ackermann+13 more
semanticscholar +1 more source
Evaluation of science advice during the COVID-19 pandemic in Sweden
Sweden was well equipped to prevent the pandemic of COVID-19 from becoming serious. Over 280 years of collaboration between political bodies, authorities, and the scientific community had yielded many successes in preventive medicine. Sweden’s population
Nele Brusselaers+7 more
doaj +1 more source
Background There is a continuing risk for COVID-19 transmission in school settings while transmission is ongoing in the community, particularly among unvaccinated populations. To ensure that schools continue to operate safely and to inform implementation
Marisa Hast+14 more
doaj +1 more source
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Background No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection,
B. Cao+64 more
semanticscholar +1 more source
COVID-19 case management strategies: what are the options for Africa?
The ongoing coronavirus disease 2019 (COVID-19) pandemic has put a strain on health systems globally. Although Africa is the least affected region to date, it has the weakest health systems and an exponential rise in cases as has been observed in other ...
Joy Luba Lomole Waya+4 more
doaj +1 more source
OpenSAFELY: factors associated with COVID-19 death in 17 million patients
Coronavirus disease 2019 (COVID-19) has rapidly affected mortality worldwide1. There is unprecedented urgency to understand who is most at risk of severe outcomes, and this requires new approaches for the timely analysis of large datasets.
E. Williamson+29 more
semanticscholar +1 more source
Moving from rhetoric to action: how Africa can use scientific evidence to halt the COVID-19 pandemic
The ongoing pandemic of the coronavirus disease 2019 has spread rapidly to all countries of the world. Africa is particularly predisposed to an escalation of the pandemic and its negative impact given its weak economy and health systems.
Olushayo Oluseun Olu+5 more
doaj +1 more source
Using social and behavioural science to support COVID-19 pandemic response
The COVID-19 pandemic represents a massive global health crisis. Because the crisis requires large-scale behaviour change and places significant psychological burdens on individuals, insights from the social and behavioural sciences can be used to help ...
J. V. Bavel+42 more
semanticscholar +1 more source
In this letter, we briefly describe how we selected and implemented the quality criteria checklist (QCC) as a critical appraisal tool in rapid systematic reviews conducted to inform public health advice, guidance and policy during the COVID-19 pandemic ...
Daphne Duval+5 more
doaj +1 more source